National Comprehensive Cancer Network

About NCCN

NCCN Launches NCCN Congress Webinar Series™: Biomarkers 101

Beginning Friday, November 3, 2017, the National Comprehensive Cancer Network® (NCCN®) will host its latest live webinar series—Biomarkers 101. Through the NCCN Congress Webinar Series™: Biomarkers 101, esteemed faculty from the NCCN Member Institutions provide updates on the latest advances in the use of biomarkers in state-of-the-art care for patients with cancer.

The science and practice of oncology are rapidly evolving based on more complete knowledge of cancer genomes and the specific genetic events that drive cancer. This knowledge, coupled with advances in medicinal chemistry, has ushered in an era of precision oncology. Use of molecular testing followed by therapies tailored to the particular molecular landscape of a patient’s disease can allow appropriate therapies to be given to patients who are most likely to benefit while avoiding unnecessary treatment of patients who are unlikely to benefit.  Although the availability of new cancer biomarkers is encouraging for diagnosis, prognosis and treatment decision-making, determining the clinical usefulness and selection of the appropriate testing methodologies can represent a daunting challenge for practitioners. 

With the field of biomarkers rapidly advancing, clinical research directly affects how oncologists manage patients. Keeping up with advances in biomarker testing allows clinicians to offer state-of-the-art care to their patients with cancer and to better identify patients that are appropriate for biomarker-directed clinical trials.

The Biomarkers 101 series includes the following webinars:

  • What Are Biomarker Tests and How Are They Approved?
    • Friday, November 3, 2017 • 12:30 – 1:30 PM EDT
    • Long Phi Le, MD, PhD, Massachusetts General Hospital
  • How Is Biomarker Testing Enriching Patient Populations for Clinical Trials & Impacting Drug Development?
    • Thursday, November 9, 2017 • 1:30 – 2:30 PM EST
    • Ross Camidge, MD, PhD, University of Colorado Cancer Center
  • Which Biomarker Test Should I Use?
    • Tuesday, December 5, 2017 • 12:00 – 1:00 PM EST
    • John D. Pfeifer, MD, PhD, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • Which Disease Sites Have Data on the Clinical Utility of Biomarkers?
    • Date & Faculty TBD

To register for Biomarkers 101, visit education.nccn.org/biomarkers